CD20+ B-cell density has also been associated with lower T-stage in HNSCC, suggesting a potential role of B-cells taming cancer progression in earlier disease stages [65], although other studies found no correlation of B-cell density with stage, indicating the need for investigation of this hypothesis in larger patient cohorts [17]. This evidence concerns the gene MS4A1 and head and neck squamous cell carcinoma.